Lundbeck Boosts US R&D Capability With $400m Abide Theraputics Bid

 
• By Mike Ward
  
nerve cells, concept for neurodegenerative and neurological disease
Lundbeck seeks new pathways to brain diseases • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business